The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 20, 2025

Filed:

Jun. 14, 2018
Applicant:

Kemijski Institut, Ljubljana, SI;

Inventors:

Roman Jerala, Ljubljana, SI;

Anja Golob Urbanc, Kranj, SI;

Assignee:

KEMIJSKI INSTITUT, Ljubljana, SI;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61P 35/00 (2006.01); C07K 14/31 (2006.01); C07K 16/30 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); A61P 35/00 (2018.01); C07K 14/31 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 2319/33 (2013.01); C07K 2319/43 (2013.01); C07K 2319/73 (2013.01);
Abstract

The invention refers to a split superantigen, divided into two fragments that by itself do not exhibit biologic activity, only upon dimerization they regain T cell activity. Scope of the invention is a screening method for detection of effective split superantigen designs, where split superantigen fragments are fused with coiled-coil forming peptides. The present invention relates to the field of cancer immunology. Each split superantigen fragment is fused with antibody or other tumor antigen specific protein, therefore only upon the binding of split superantigen-antibody fusion proteins to the tumor antigen, split superatigen fragments comes to proximity and reconstitute into biologically active form that activates T-cell response.


Find Patent Forward Citations

Loading…